Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Hims and Hers is airing an ad about its copycat GLP-1 drugs during Sunday’s Super Bowl. Critics say it violates FDA rules.

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

Filed in the Superior Court of the State of California, County of Ventura, the lawsuit says Kennametal stole trade secrets and contractually protected confidential information from MachiningCloud and ...

Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 ...

An advocacy group criticizes Hims & Hers Health for allegedly misleading Super Bowl ad promoting weight loss products, violating FDA regulations. Read more here.

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.

The ASX is set to rise by 0.7% or 59 points in early trading this morning, following the US up after a strong day of growth ...

Novo Nordisk's CEO took a $1.5 million pay cut in 2024 as the pharma giant's share price tanked and it missed profit and DEI ...

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.